ß-Modified Phosphoric Acid Compound Precursor, ß-Modified Phosphoric Acid Compound, Reaction Inhibitor and Medicine Containing the Same, and Method for Inhibiting Reaction
申请人:Japan Science and Technology Agency
公开号:US20210284679A1
公开(公告)日:2021-09-16
A β-modified phosphoric acid compound precursor having a partial structure represented by
where A
1
represents —SR
1
, —S—S—R
1
, —SeR
1
, or —X, where X is a halogen selected from fluorine, chlorine, bromine, and iodine; R
1
represents hydrogen, an alkyl group having 1 to 20 carbon atoms, or the like; L
1
represents hydrogen, an alkyl group having 1 to 20 carbon atoms, or the like; L
2
represents an alkyl group having 1 to 20 carbon atoms, or the like; L
1
and L
2
may be linked to each other to form a 4 to 6-membered ring structure; L
1
and L
2
may each have a substituent; and the symbol * represents a bond to be bonded to a phosphate group by phosphorylation. Further, provided are a reaction inhibitor and a medicine, each of which includes the β-modified phosphoric acid compound precursor.
一种β-改性的磷酸化合物前体,具有以下部分结构:其中A1代表—SR1,—S—S—R1,—SeR1或—X,其中X是从氟、氯、溴和碘中选择的卤素;R1代表氢、具有1至20个碳原子的烷基或类似物;L1代表氢、具有1至20个碳原子的烷基或类似物;L2代表具有1至20个碳原子的烷基或类似物;L1和L2可以连接在一起形成4至6个成员的环状结构;L1和L2可以各自具有取代基;符号*表示通过磷酸化作用与磷酸基结合的键。此外,还提供了一种反应抑制剂和一种药物,其中每种药物均包括β-改性磷酸化合物前体。